$23.61
Currently 13 wall-street analysts regularly analyze the financials of Catalyst Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 13 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc (CPRX) have a share price target of $34.86. This median of share price forecast represents a 47.64% upside from the latest price of $23.61 as on 13.12.25.
As per the chart shown above, analysts believe that the Catalyst Pharmaceuticals Inc (CPRX) share price will touch around $34.86 in next 12-months.
Below is a chart showing the percentage difference between Catalyst Pharmaceuticals Inc's share price and its median forecast price. As on 13.12.25, the difference is -34.91%
Based on 13 analysts tracking and researching Catalyst Pharmaceuticals Inc (CPRX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 7 | 7 | 7 |
| Outperform | 3 | 5 | 5 |
| Hold | 1 | 1 | 1 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |